Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy L Bartlett

Showing results (1-10 of 287) with videos related to

Pageof 29
Sort By:
Hematology. American Society of Hematology. Education Program|January 18, 2011
The present: optimizing therapy--too much or too little?Nancy L Bartlett
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2021
Optimizing Second-Line Therapy for Hodgkin Lymphoma: A Work in ProgressNancy L Bartlett
Clinical Advances in Hematology & Oncology : H&O|April 10, 2015
Highlights in lymphoma from the 2013 American Society of Hematology Annual Meeting and Exposition: commentaryNancy L Bartlett
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Limited-stage Hodgkin lymphoma: optimal chemotherapy and the role of radiotherapyNancy L Bartlett
Clinical Advances in Hematology & Oncology : H&O|January 30, 2014
Treatment of nodular lymphocyte-predominant Hodgkin lymphoma-"do no harm"Nancy L Bartlett
Blood|March 18, 2021
Protect our children: Hodgkin lymphoma survivorsNancy L Bartlett
The New England Journal of Medicine|December 12, 2022
Bispecific Antibodies in Lymphoma - Another Win for T CellsNancy L Bartlett
Hematology. American Society of Hematology. Education Program|December 4, 2020
Approaches to aggressive B-cell lymphomas in less fit patientsNancy L Bartlett
Clinical Advances in Hematology & Oncology : H&O|May 30, 2014
CommentaryNancy L Bartlett
Hematology. American Society of Hematology. Education Program|November 24, 2005
Therapies for relapsed Hodgkin lymphoma: transplant and non-transplant approaches including immunotherapyNancy L Bartlett
Pageof 29

Showing results (1-10 of 287) with videos related to

Sort By:
Pageof 29
Hematology. American Society of Hematology. Education Program|January 18, 2011
The present: optimizing therapy--too much or too little?Nancy L Bartlett
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2021
Optimizing Second-Line Therapy for Hodgkin Lymphoma: A Work in ProgressNancy L Bartlett
Clinical Advances in Hematology & Oncology : H&O|April 10, 2015
Highlights in lymphoma from the 2013 American Society of Hematology Annual Meeting and Exposition: commentaryNancy L Bartlett
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Limited-stage Hodgkin lymphoma: optimal chemotherapy and the role of radiotherapyNancy L Bartlett
Clinical Advances in Hematology & Oncology : H&O|January 30, 2014
Treatment of nodular lymphocyte-predominant Hodgkin lymphoma-"do no harm"Nancy L Bartlett
Blood|March 18, 2021
Protect our children: Hodgkin lymphoma survivorsNancy L Bartlett
The New England Journal of Medicine|December 12, 2022
Bispecific Antibodies in Lymphoma - Another Win for T CellsNancy L Bartlett
Hematology. American Society of Hematology. Education Program|December 4, 2020
Approaches to aggressive B-cell lymphomas in less fit patientsNancy L Bartlett
Clinical Advances in Hematology & Oncology : H&O|May 30, 2014
CommentaryNancy L Bartlett
Hematology. American Society of Hematology. Education Program|November 24, 2005
Therapies for relapsed Hodgkin lymphoma: transplant and non-transplant approaches including immunotherapyNancy L Bartlett
Pageof 29